Does CAMRELIZUMAB Cause Hepatic failure? 7 Reports in FDA Database

Q: Does CAMRELIZUMAB cause Hepatic failure?

7 reports of Hepatic failure have been filed with the FDA for CAMRELIZUMAB, representing 1.6% of all CAMRELIZUMAB adverse event reports.

Q: How dangerous is Hepatic failure from CAMRELIZUMAB?

Of 7 reports, 4 (57.1%) resulted in death and 2 required hospitalization.

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Hepatic failure have been filed in association with CAMRELIZUMAB. This represents 1.6% of all adverse event reports for CAMRELIZUMAB.

Reports of Hepatic failure with CAMRELIZUMAB

1.6%

of all CAMRELIZUMAB reports

Deaths

Hospitalizations

How Dangerous Is Hepatic failure From CAMRELIZUMAB?

Of the 7 reports, 4 (57.1%) resulted in death, 2 (28.6%) required hospitalization.

Is Hepatic failure Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for CAMRELIZUMAB. However, 7 reports have been filed with the FAERS database.

What Other Side Effects Does CAMRELIZUMAB Cause?

Myelosuppression (70) Fatigue (60) Nausea (60) Vomiting (59) Diarrhoea (54) Anaemia (53) Hypothyroidism (53) Off label use (52) Rash (50) Thrombocytopenia (46)

What Other Drugs Cause Hepatic failure?

ACETAMINOPHEN (1,392) RIBAVIRIN (888) CYCLOPHOSPHAMIDE (629) METHOTREXATE (598) BEVACIZUMAB (558) SOFOSBUVIR (525) RITUXIMAB (513) VINCRISTINE (468) DOXORUBICIN (462) PREDNISOLONE (425)

Which CAMRELIZUMAB Alternatives Have Lower Hepatic failure Risk?

CAMRELIZUMAB vs CANAGLIFLOZIN CAMRELIZUMAB vs CANAGLIFLOZIN\METFORMIN CAMRELIZUMAB vs CANAKINUMAB CAMRELIZUMAB vs CANDESARTAN CAMRELIZUMAB vs CANDESARTAN CILEXETIL

CAMRELIZUMAB Full Profile All Hepatic failure Reports All Drugs Causing Hepatic failure CAMRELIZUMAB Demographics